Skip to main content

In Vivo Antitumor Evaluation of Antibiotics. Selected Results from the Drug Evaluation Program of the National Cancer Institute, U.S.A

  • Chapter
Antitumor Antibiotics

Abstract

While we most often relate antibiotic chemotherapy to erradication of infectious foreign organisms, we must remain aware of the value of antibiotics (e.g. anthracyclines, bleomycin, actinomycin D, mitomycin C, mithramycin, L-asparaginase) as antitumor drugs [5, 12]. Moreover, fermentation products continue to represent a fruitful field for discovering new materials with clinical anticancer potential. During 1976, the Division of Cancer Treatment (DCT), National Cancer Institute (NCI) examined over 1000 fermentation broths for activity against one or more animal tumors. The yield of “active” materials from this in vivo screening program are presented elsewhere in this volume [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Corbett, T. H., Griswold, D. P., jr., Roberts, B. J., Peckham, J. C., Schabel, F. M., jr.: Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinoma. Cancer (in press).

    Google Scholar 

  2. Douros, J.: Present National Cancer Institutes Fermentation Development Program. (See Chapter 4 of this book.)

    Google Scholar 

  3. Geran, R. I., Greenberg, N. H., Macdonald, M. M., Schumacher, A. M., Abbott, B. J.: Protocols for screening chemical agents and natural products against animal tumors and other biological systems (Third Edition). Cancer Chemother. Rep. Part 3, 3 (2), 1–5 (1972).

    Google Scholar 

  4. Goldin, A., Serpick, A. M., Mantel, N.: A commentary. Experimental screening procedures and clinical predictability value. Cancer Chemother. Rep. 50, 173–218 (1966).

    PubMed  CAS  Google Scholar 

  5. Holland, J. F., Frei, E. (Eds.): Cancer Medicine. Philadelphia: Lea and Febiger 1973.

    Google Scholar 

  6. See Umezawa, H.: Principles of antitumor antibiotic chemotherapy, 817–826;

    Google Scholar 

  7. Dimarco, A., Lenaz, L.: Daunomycin and Adriamycin, 826–835;

    Google Scholar 

  8. Friedman, P. A., Cerami, A.: Actinomycin, 835–839;

    Google Scholar 

  9. Capizzi, R. L., Handschumacher, R. E.: Asparaginase, 850–859;

    Google Scholar 

  10. Goldin, A., Carter, S. K: Screening and evaluation of antitumor agents, 605–628.

    Google Scholar 

  11. Lippman, M. M., Laster, W. R., Abbott, B. J., Venditti, J. M., Baratta, M.: Antitumor activity of Macromomycin B (NSC-170105) against murine leukemias, melanoma, and lung carcinoma. Cancep Res. 35, 939–945 (1975).

    PubMed  CAS  Google Scholar 

  12. Martin, D. S., Fugmann, R. A., Stolfi, R. L., Hayworth, P. E.: Solid tumor animal model therapeutically predictive for human breast cancer. Cancer Chemother. Rep. Part 2, 5 (1), 89–109 (1975).

    Google Scholar 

  13. Neil, G. L.: Detection and Assay of Antitumor Antibiotics. (See Chapter 2 of this book.)

    Google Scholar 

  14. Rosazza, J.: Antitumor Antibiotic Activation, Biotransformation and Derivation by Microbial Systems. (See Chapter 6 of this book.)

    Google Scholar 

  15. Venditti, J. M.: Forward in “Protocols for screening chemical agents and natural products against animal tumors and other biological systems (Third Edition)”. Cancer Chemother. Rep. Part 3, 3 (2), 1–5 (1972).

    Google Scholar 

  16. Venditti, J. M.: Drug evaluation branch program: Report to the screening contractors. Cancer Chemother. Rep. Part 2, 5 (1) 1–4 (1975).

    Google Scholar 

  17. Venditti, J. M.: Relevance of transplantable animal-tumor systems to the selection of new agents for clinical trial. In: Pharmacological Basis for Cancer Chemotherapy. Baltimore: Williams and Wilkins Co. 1975, pp. 245–270

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Venditti, J.M., Johnson, R.K. (1978). In Vivo Antitumor Evaluation of Antibiotics. Selected Results from the Drug Evaluation Program of the National Cancer Institute, U.S.A. In: Carter, S.K., Umezawa, H., Douros, J., Sakurai, Y. (eds) Antitumor Antibiotics. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 63. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81219-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81219-4_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81221-7

  • Online ISBN: 978-3-642-81219-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics